Home Newsfeeds Raymond James Maintains Outperform on First Foundation, Lowers Price Target to $25

Raymond James Maintains Outperform on First Foundation, Lowers Price Target to $25

Raymond James maintains First Foundation (NASDAQ:FFWM) with a Outperform and lowers the price target from $28 to $25.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Raymond James maintains First Foundation (NASDAQ:FFWM) with a Outperform and lowers the price target from $28 to $25.

Canon Earlier Reported Q2 EPS $0.41 Misses $0.50 Estimate, Sales $7.29B Miss $7.49B Estimate

By Benzinga Newsdesk

July 26, 10:06 AM

Canon (NYSE:CAJ) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.50 by 18 percent. This is a 22.64 percent decrease over earnings of $0.53 per share from the same period

CAJ

ReShape Lifesciences Shares Soar As FDA Announced Clearance To GIBI HD Calibration Tubes In Weight Loss Procedures

By Ragothaman Srinivasan

August 10, 12:42 PM

The U.S. Food and Drug Administration (FDA) has announced 510(k) clearance to ReShape Lifesciences’ (NASDAQ: RSLS) Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube for use in gastric and bariatric surgical procedures.

RSLS

What New China Semiconductor Restrictions Mean For US Investors

By Wayne Duggan

October 10, 12:26 PM

U.S.-listed Chinese stocks tumbled on Monday after the U.S. Department of Commerce announced a new set of rules restricting the sale of advanced computing semiconductors or related manufacturing equipment to China.

AAPL